Advanced search
Publication Cover
Expert Opinion on Drug Discovery Volume 12, 2017 - Issue 7
Submit an article Journal homepage
616
Views
7
CrossRef citations to date
0
Altmetric
Review

New routes in frontotemporal dementia drug discovery

Laura De ContiBiotechnology Development Group, International Centre for Genetic Engineering and Biotechnology, Trieste, ItalyView further author information
,
Barbara BorroniCentre for Neurodegenerative Disorders - Neurology Unit, University of Brescia, Brescia, ItalyView further author information
&
Marco BaralleBiotechnology Development Group, International Centre for Genetic Engineering and Biotechnology, Trieste, ItalyCorrespondence[email protected]
View further author information
Pages 659-671 | Received 22 Feb 2017, Accepted 08 May 2017, Published online: 02 Jun 2017

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Giancarlo Logroscino, Bruno P. Imbimbo, Madia Lozupone, Rodolfo Sardone, Rosa Capozzo, Petronilla Battista, Chiara Zecca, Vittorio Dibello, Gianluigi Giannelli, Antonello Bellomo, Antonio Greco, Antonio Daniele, Davide Seripa & Francesco Panza. (2019) Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs. Expert Opinion on Pharmacotherapy 20:9, pages 1091-1107.
Read now
Francesco Panza, Bruno P. Imbimbo, Madia Lozupone, Antonio Greco, Davide Seripa, Giancarlo Logroscino, Antonio Daniele & Carlo Colosimo. (2019) Disease-modifying therapies for tauopathies: agents in the pipeline. Expert Review of Neurotherapeutics 19:5, pages 397-408.
Read now

Articles from other publishers (5)

Emmanuelle C. Genin, Mélanie Abou-Ali & Véronique Paquis-Flucklinger. (2023) Mitochondria, a Key Target in Amyotrophic Lateral Sclerosis Pathogenesis. Genes 14:11, pages 1981.
Crossref
Agnieszka Zagórska, Anna Czopek, Monika Fryc, Anna Jaromin & Ben J. Boyd. (2023) Drug Discovery and Development Targeting Dementia. Pharmaceuticals 16:2, pages 151.
Crossref
Liam Rodney Garrett & Teresa Niccoli. (2022) Frontotemporal Dementia and Glucose Metabolism. Frontiers in Neuroscience 16.
Crossref
Lucia Cragnaz, Greta Spinelli, Laura De Conti, Emilie A. Bureau, Janet Brownlees, Fabian Feiguin, Valentina Romano, Natasa Skoko, Raffaella Klima, Catherine A. Kettleborough, Francisco E. Baralle & Marco Baralle. (2021) Thioridazine reverts the phenotype in cellular and Drosophila models of amyotrophic lateral sclerosis by enhancing TDP-43 aggregate clearance. Neurobiology of Disease 160, pages 105515.
Crossref
Francesco Panza, Madia Lozupone, Davide Seripa, Antonio Daniele, Mark Watling, Gianluigi Giannelli & Bruno P. Imbimbo. (2020) Development of disease-modifying drugs for frontotemporal dementia spectrum disorders. Nature Reviews Neurology 16:4, pages 213-228.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.